| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Seneca Growth Capital VCT plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.14 |
| 52 Week High | UK£0.24 |
| 52 Week Low | UK£0.095 |
| Beta | 0.39 |
| 1 Month Change | 0% |
| 3 Month Change | -6.90% |
| 1 Year Change | -34.15% |
| 3 Year Change | -58.46% |
| 5 Year Change | -65.38% |
| Change since IPO | -86.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| HYG | GB Capital Markets | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 1.1% |
| 1Y | -34.1% | 11.7% | 6.8% |
Return vs Industry: HYG underperformed the UK Capital Markets industry which returned 9.6% over the past year.
Return vs Market: HYG underperformed the UK Market which returned 6.1% over the past year.
Price Volatility
| HYG volatility | |
|---|---|
| HYG Average Weekly Movement | 2.0% |
| Capital Markets Industry Average Movement | 4.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: HYG has not had significant price volatility in the past 3 months.
Volatility Over Time: HYG's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | n/a | www.senecavct.co.uk |
Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies.
Seneca Growth Capital VCT plc Fundamentals Summary
| HYG fundamental statistics | |
|---|---|
| Market cap | UK£14.29m |
| Earnings (TTM) | -UK£2.67m |
| Revenue (TTM) | n/a |
-1.8x
P/S Ratio-1.6x
P/E RatioIs HYG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYG income statement (TTM) | |
|---|---|
| Revenue | -UK£2.40m |
| Cost of Revenue | UK£0 |
| Gross Profit | -UK£2.40m |
| Other Expenses | UK£273.00k |
| Earnings | -UK£2.67m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.084 |
| Gross Margin | 100.00% |
| Net Profit Margin | 111.38% |
| Debt/Equity Ratio | 0% |
How did HYG perform over the long term?
See historical performance and comparison